132 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ghasemi DR, Sill M, Okonechnikov K, Korshunov A, Yip S, Schutz PW, Scheie D, Kruse A, Harter PN, Kastelan M, Wagner M, Hartmann C, Benzel J, Maass KK, Khasraw M, et al. MYCN amplification drives an aggressive form of spinal ependymoma. Acta Neuropathologica. PMID 31414211 DOI: 10.1007/s00401-019-02056-2  0.68
2019 Galli R, Uckermann O, Sehm T, Leipnitz E, Hartmann C, Sahm F, Koch E, Schackert G, Steiner G, Kirsch M. Identification of distinctive features in human intracranial tumors by label-free nonlinear multimodal microscopy. Journal of Biophotonics. e201800465. PMID 31194284 DOI: 10.1002/jbio.201800465  0.68
2019 Hou Y, Pinheiro J, Sahm F, Reuss DE, Schrimpf D, Stichel D, Casalini B, Koelsche C, Sievers P, Wefers AK, Reinhardt A, Ebrahimi A, Fernández-Klett F, Pusch S, Meier J, ... ... Hartmann C, et al. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA. Acta Neuropathologica. PMID 30759284 DOI: 10.1007/s00401-019-01969-2  0.68
2019 Christians A, Poisel E, Hartmann C, von Deimling A, Pusch S. Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation. International Journal of Cancer. PMID 30614533 DOI: 10.1002/ijc.32107  0.68
2018 Sievers P, Stichel D, Hielscher T, Schrimpf D, Reinhardt A, Wefers AK, Reuss D, Jones DTW, Bewerunge-Hudler M, Hartmann C, Baumgarten P, Wirsching HG, Winther-Kristensen B, Brokinkel B, Ketter R, et al. Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p. Acta Neuropathologica. PMID 30382370 DOI: 10.1007/s00401-018-1924-x  0.68
2018 Hong B, Banan R, Christians A, Nakamura M, Lalk M, Lehmann U, Hartmann C, Krauss JK. Cerebellar glioblastoma: a clinical series with contemporary molecular analysis. Acta Neurochirurgica. PMID 30203362 DOI: 10.1007/s00701-018-3673-y  0.32
2018 Sievers P, Stichel D, Schrimpf D, Sahm F, Koelsche C, Reuss DE, Wefers AK, Reinhardt A, Huang K, Ebrahimi A, Hou Y, Pajtler KW, Pfister SM, Hasselblatt M, Stummer W, ... ... Hartmann C, et al. FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma. Acta Neuropathologica. PMID 29978331 DOI: 10.1007/s00401-018-1882-3  0.68
2018 Deng MY, Sill M, Chiang J, Schittenhelm J, Ebinger M, Schuhmann MU, Monoranu CM, Milde T, Wittmann A, Hartmann C, Sommer C, Paulus W, Gärtner J, Brück W, Rüdiger T, et al. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathologica. PMID 29766299 DOI: 10.1007/s00401-018-1865-4  0.68
2018 Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, Huang K, Wefers AK, Hovestadt V, Sill M, Gramatzki D, Felsberg J, Reifenberger G, Koch A, ... ... Hartmann C, et al. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica. PMID 29564591 DOI: 10.1007/s00401-018-1837-8  0.68
2018 Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, ... ... Hartmann C, et al. DNA methylation-based classification of central nervous system tumours. Nature. PMID 29539639 DOI: 10.1038/nature26000  0.68
2017 Banan R, Christians A, Bartels S, Lehmann U, Hartmann C. Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant. Acta Neuropathologica Communications. 5: 98. PMID 29246238 DOI: 10.1186/s40478-017-0500-2  0.32
2017 Beyer U, Brand F, Martens H, Weder J, Christians A, Elyan N, Hentschel B, Westphal M, Schackert G, Pietsch T, Hong B, Krauss JK, Samii A, Raab P, Das A, ... ... Hartmann C, et al. Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis. Acta Neuropathologica. PMID 29030706 DOI: 10.1007/s00401-017-1774-y  0.4
2017 Yesilöz Ü, Kirches E, Hartmann C, Scholz J, Kropf S, Sahm F, Nakamura M, Mawrin C. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. Neuro-Oncology. PMID 28482067 DOI: 10.1093/neuonc/nox018  0.68
2016 Schliesser MG, Claus R, Hielscher T, Grimm C, Weichenhan D, Blaes J, Wiestler B, Hau P, Schramm J, Sahm F, Weiß EK, Weiler M, Baer C, Schmidt-Graf F, Schackert G, ... ... Hartmann C, et al. Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget. PMID 27880937 DOI: 10.18632/oncotarget.13452  0.68
2016 Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJ, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, et al. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. The Lancet. Oncology. PMID 27686946 DOI: 10.1016/S1470-2045(16)30313-8  0.68
2016 Wick W, Roth P, Hartmann C, Hau P, Nakamura M, Stockhammer F, Sabel MC, Wick A, Koeppen S, Ketter R, Vajkoczy P, Eyupoglu I, Kalff R, Happold C, Galldiks N, et al. Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. Neuro-Oncology. PMID 27370396 DOI: 10.1093/neuonc/now133  0.68
2016 Behling F, Barrantes-Freer A, Skardelly M, Nieser M, Christians A, Stockhammer F, Rohde V, Tatagiba M, Hartmann C, Stadelmann C, Schittenhelm J. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Diagnostic Pathology. 11: 55. PMID 27350555 DOI: 10.1186/s13000-016-0506-2  0.32
2016 Mock A, Geisenberger C, Orlik C, Warta R, Schwager C, Jungk C, Dutruel C, Geiselhart L, Weichenhan D, Zucknick M, Nied AK, Friauf S, Exner J, Capper D, Hartmann C, et al. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients. International Journal of Cancer. PMID 26934681 DOI: 10.1002/ijc.30069  0.68
2016 Röhrich M, Koelsche C, Schrimpf D, Capper D, Sahm F, Kratz A, Reuss J, Hovestadt V, Jones DT, Bewerunge-Hudler M, Becker A, Weis J, Mawrin C, Mittelbronn M, Perry A, ... ... Hartmann C, et al. Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathologica. PMID 26857854 DOI: 10.1007/s00401-016-1540-6  0.68
2015 Abuharbid G, Esmaeilzadeh M, Hartmann C, Hermann EJ, Krauss JK. Multiple desmoplastic infantile gliomas-therapeutic challenges. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. PMID 26584553 DOI: 10.1007/s00381-015-2958-1  0.68
2015 Stefanits H, Bieńkowski M, Galanski M, Mitulović G, Ströbel T, Gelpi E, Ribalta T, Broholm H, Hartmann C, Kros JM, Preusser M, Hainfellner JA. KINFix - A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimens. Clinical Neuropathology. PMID 26521938 DOI: 10.5414/NP300907  0.68
2015 Yildiz Ö, Pul R, Raab P, Hartmann C, Skripuletz T, Stangel M. Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis. Journal of Neuroinflammation. 12: 175. PMID 26376717 DOI: 10.1186/s12974-015-0398-1  0.68
2015 Reuss DE, Mamatjan Y, Schrimpf D, Capper D, Hovestadt V, Kratz A, Sahm F, Koelsche C, Korshunov A, Olar A, Hartmann C, Reijneveld JC, Wesseling P, Unterberg A, Platten M, et al. IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathologica. 129: 867-73. PMID 25962792 DOI: 10.1007/s00401-015-1438-8  0.68
2015 Campos B, Weisang S, Osswald F, Ali R, Sedlmeier G, Bageritz J, Mallm JP, Hartmann C, von Deimling A, Popanda O, Goidts V, Plass C, Unterberg A, Schmezer P, Burhenne J, et al. Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma. Glia. PMID 25944104 DOI: 10.1002/glia.22849  0.68
2015 Geisenberger C, Mock A, Warta R, Rapp C, Schwager C, Korshunov A, Nied AK, Capper D, Brors B, Jungk C, Jones D, Collins VP, Ichimura K, Bäcklund LM, Schnabel E, ... ... Hartmann C, et al. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain. Acta Neuropathologica. PMID 25931051 DOI: 10.1007/s00401-015-1427-y  0.68
2015 Abuharbid G, Esmaeilzadeh M, Hartmann C, Hermann EJ, Krauss JK. Desmoplastic infantile astrocytoma with multiple intracranial and intraspinal localizations at presentation. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 31: 959-64. PMID 25930721 DOI: 10.1007/s00381-015-2715-5  0.68
2015 Weller M, Weber RG, Willscher E, Riehmer V, Hentschel B, Kreuz M, Felsberg J, Beyer U, Löffler-Wirth H, Kaulich K, Steinbach JP, Hartmann C, Gramatzki D, Schramm J, Westphal M, et al. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathologica. 129: 679-93. PMID 25783747 DOI: 10.1007/s00401-015-1409-0  0.68
2015 Koelsche C, Hovestadt V, Jones DT, Capper D, Sturm D, Sahm F, Schrimpf D, Adeberg S, Böhmer K, Hagenlocher C, Mechtersheimer G, Kohlhof P, Mühleisen H, Beschorner R, Hartmann C, et al. Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles. Brain Pathology (Zurich, Switzerland). 25: 202-8. PMID 25399693 DOI: 10.1111/bpa.12228  0.68
2014 Wick W, Fricke H, Junge K, Kobyakov G, Martens T, Heese O, Wiestler B, Schliesser MG, von Deimling A, Pichler J, Vetlova E, Harting I, Debus J, Hartmann C, Kunz C, et al. A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6304-13. PMID 25338498 DOI: 10.1158/1078-0432.CCR-14-0951-T  0.68
2014 Sahm F, Reuss D, Koelsche C, Capper D, Schittenhelm J, Heim S, Jones DT, Pfister SM, Herold-Mende C, Wick W, Mueller W, Hartmann C, Paulus W, von Deimling A. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. Acta Neuropathologica. 128: 551-9. PMID 25143301 DOI: 10.1007/s00401-014-1326-7  0.68
2014 Wiestler B, Capper D, Hovestadt V, Sill M, Jones DT, Hartmann C, Felsberg J, Platten M, Feiden W, Keyvani K, Pfister SM, Wiestler OD, Meyermann R, Reifenberger G, Pietsch T, et al. Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-Oncology. 16: 1630-8. PMID 25028501 DOI: 10.1093/neuonc/nou138  0.68
2014 Wiestler B, Capper D, Sill M, Jones DT, Hovestadt V, Sturm D, Koelsche C, Bertoni A, Schweizer L, Korshunov A, Weiß EK, Schliesser MG, Radbruch A, Herold-Mende C, Roth P, ... ... Hartmann C, et al. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathologica. 128: 561-71. PMID 25008768 DOI: 10.1007/s00401-014-1315-x  0.68
2014 Aumüller M, Sykora KW, Hartmann C, Hermann EJ, Krauss JK. Primary intracranial leiomyosarcoma of the torcular Herophili associated with Fanconi anemia and allogenic stem cell transplantation. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 30: 1613-6. PMID 24752708 DOI: 10.1007/s00381-014-2422-7  0.68
2014 Reifenberger G, Weber RG, Riehmer V, Kaulich K, Willscher E, Wirth H, Gietzelt J, Hentschel B, Westphal M, Simon M, Schackert G, Schramm J, Matschke J, Sabel MC, Gramatzki D, ... ... Hartmann C, et al. Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. International Journal of Cancer. Journal International Du Cancer. 135: 1822-31. PMID 24615357 DOI: 10.1002/ijc.28836  0.68
2014 Reuss DE, Habel A, Hagenlocher C, Mucha J, Ackermann U, Tessmer C, Meyer J, Capper D, Moldenhauer G, Mautner V, Frappart PO, Schittenhelm J, Hartmann C, Hagel C, Katenkamp K, et al. Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms. Acta Neuropathologica. 127: 565-72. PMID 24464231 DOI: 10.1007/s00401-014-1246-6  0.68
2014 Blaes J, Weiler M, Sahm F, Hentschel B, Osswald M, Czabanka M, Thomé CM, Schliesser MG, Pusch S, Luger S, Winkler F, Radbruch A, Jugold M, Simon M, Steinbach JP, ... ... Hartmann C, et al. NDRG1 prognosticates the natural course of disease in WHO grade II glioma. Journal of Neuro-Oncology. 117: 25-32. PMID 24395351 DOI: 10.1007/s11060-013-1357-2  0.68
2014 Nishiyama Y, Sasaki H, Nagahisa S, Adachi K, Hayashi T, Yoshida K, Kawase T, Hattori N, Murayama K, Abe M, Hasegawa M, Hirose Y. Radiological features of supratentorial gliomas are associated with their genetic aberrations. Neurosurgical Review. 37: 291-9; discussion 29. PMID 24363075 DOI: 10.1007/s10143-013-0515-5  0.68
2014 Koelsche C, Sahm F, Wöhrer A, Jeibmann A, Schittenhelm J, Kohlhof P, Preusser M, Romeike B, Dohmen-Scheufler H, Hartmann C, Mittelbronn M, Becker A, von Deimling A, Capper D. BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression. Brain Pathology (Zurich, Switzerland). 24: 221-9. PMID 24345274 DOI: 10.1111/bpa.12111  0.68
2014 Heim S, Beschorner R, Mittelbronn M, Keyvani K, Riemenschneider MJ, Vajtai I, Hartmann C, Acker T, Blümcke I, Paulus W, Hasselblatt M. Increased mitotic and proliferative activity are associated with worse prognosis in papillary tumors of the pineal region. The American Journal of Surgical Pathology. 38: 106-10. PMID 24121176 DOI: 10.1097/PAS.0b013e31829e492d  0.68
2013 Hong B, Nakamura M, Hartmann C, Brandis A, Ganser A, Krauss JK. Delayed distant spinal metastasis in thymomas. Spine. 38: E1709-13. PMID 24335640 DOI: 10.1097/BRS.0000000000000029  0.68
2013 Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, Jones DT, Kool M, Northcott PA, Wiestler B, Böhmer K, Meyer J, Mawrin C, Hartmann C, Mittelbronn M, Platten M, et al. Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathologica. 126: 907-15. PMID 24154961 DOI: 10.1007/s00401-013-1195-5  0.68
2013 Sahm F, Bissel J, Koelsche C, Schweizer L, Capper D, Reuss D, Böhmer K, Lass U, Göck T, Kalis K, Meyer J, Habel A, Brehmer S, Mittelbronn M, Jones DT, ... ... Hartmann C, et al. AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry. Acta Neuropathologica. 126: 757-62. PMID 24096618 DOI: 10.1007/s00401-013-1187-5  0.68
2013 Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von Deimling A, Weller M. Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5146-57. PMID 23918605 DOI: 10.1158/1078-0432.CCR-13-0017  0.68
2013 Wick W, Steinbach JP, Platten M, Hartmann C, Wenz F, von Deimling A, Shei P, Moreau-Donnet V, Stoffregen C, Combs SE. Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation. Neuro-Oncology. 15: 1405-12. PMID 23911595 DOI: 10.1093/neuonc/not100  0.68
2013 Liu X, Wu G, Shan Y, Hartmann C, von Deimling A, Xing M. Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma. Cell Cycle (Georgetown, Tex.). 12: 1637-8. PMID 23603989 DOI: 10.4161/cc.24662  0.68
2013 Sahm F, Lass U, Herold-Mende C, von Deimling A, Hartmann C, Mueller W. Analysis of CIC-associated CpG island methylation in oligoastrocytoma. Neuropathology and Applied Neurobiology. 39: 831-6. PMID 23521081 DOI: 10.1111/nan.12045  0.68
2013 Reuss DE, Piro RM, Jones DT, Simon M, Ketter R, Kool M, Becker A, Sahm F, Pusch S, Meyer J, Hagenlocher C, Schweizer L, Capper D, Kickingereder P, Mucha J, ... ... Hartmann C, et al. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathologica. 125: 351-8. PMID 23404370 DOI: 10.1007/s00401-013-1093-x  0.68
2013 van den Bent MJ, Hartmann C, Preusser M, Ströbel T, Dubbink HJ, Kros JM, von Deimling A, Boisselier B, Sanson M, Halling KC, Diefes KL, Aldape K, Giannini C. Interlaboratory comparison of IDH mutation detection. Journal of Neuro-Oncology. 112: 173-8. PMID 23358936 DOI: 10.1007/s11060-013-1056-z  0.68
2013 Purrucker JC, Hund E, Ringleb PA, Hartmann C, Rohde S, Schönland S, Steiner T. Cerebral amyloid angiopathy--an underdiagnosed entity in younger adults with lobar intracerebral hemorrhage? Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 20: 45-7. PMID 23231422 DOI: 10.3109/13506129.2012.746937  0.68
2013 Lass U, Hartmann C, Capper D, Herold-Mende C, von Deimling A, Meiboom M, Mueller W. Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas. Brain Pathology (Zurich, Switzerland). 23: 311-8. PMID 23107103 DOI: 10.1111/bpa.12003  0.68
2012 Bradtmöller M, Hartmann C, Zietsch J, Jäschke S, Mautner VF, Kurtz A, Park SJ, Baier M, Harder A, Reuss D, von Deimling A, Heppner FL, Holtkamp N. Impaired Pten expression in human malignant peripheral nerve sheath tumours. Plos One. 7: e47595. PMID 23139750 DOI: 10.1371/journal.pone.0047595  0.68
2012 Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, ... ... Hartmann C, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 22: 425-37. PMID 23079654 DOI: 10.1016/j.ccr.2012.08.024  0.68
2012 Ott M, Litzenburger UM, Sahm F, Rauschenbach KJ, Tudoran R, Hartmann C, Marquez VE, von Deimling A, Wick W, Platten M. Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase. Plos One. 7: e47663. PMID 23077658 DOI: 10.1371/journal.pone.0047663  0.68
2012 Dokic I, Hartmann C, Herold-Mende C, Régnier-Vigouroux A. Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress. Glia. 60: 1785-800. PMID 22951908 DOI: 10.1002/glia.22397  0.68
2012 Sahm F, Koelsche C, Meyer J, Pusch S, Lindenberg K, Mueller W, Herold-Mende C, von Deimling A, Hartmann C. CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas. Acta Neuropathologica. 123: 853-60. PMID 22588899 DOI: 10.1007/s00401-012-0993-5  0.68
2012 Ahmadi R, Stockhammer F, Becker N, Hohlen K, Misch M, Christians A, Dictus C, Herold-Mende C, Capper D, Unterberg A, von Deimling A, Wick W, Hartmann C. No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas. Journal of Neuro-Oncology. 109: 15-22. PMID 22528790 DOI: 10.1007/s11060-012-0863-y  0.68
2012 Christians A, Hartmann C, Benner A, Meyer J, von Deimling A, Weller M, Wick W, Weiler M. Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma. Plos One. 7: e33449. PMID 22428052 DOI: 10.1371/journal.pone.0033449  0.68
2012 Campos B, Warta R, Chaisaingmongkol J, Geiselhart L, Popanda O, Hartmann C, von Deimling A, Unterberg A, Plass C, Schmezer P, Herold-Mende C. Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas. International Journal of Cancer. Journal International Du Cancer. 131: 1963-8. PMID 22275178 DOI: 10.1002/ijc.27446  0.68
2012 Hegi ME, Janzer RC, Lambiv WL, Gorlia T, Kouwenhoven MC, Hartmann C, von Deimling A, Martinet D, Besuchet Schmutz N, Diserens AC, Hamou MF, Bady P, Weller M, van den Bent MJ, Mason WP, et al. Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial. Acta Neuropathologica. 123: 841-52. PMID 22249618 DOI: 10.1007/s00401-011-0938-4  0.68
2012 Stockhammer F, Misch M, Helms HJ, Lengler U, Prall F, von Deimling A, Hartmann C. IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure. 21: 194-7. PMID 22217666 DOI: 10.1016/j.seizure.2011.12.007  0.68
2012 Augustin I, Goidts V, Bongers A, Kerr G, Vollert G, Radlwimmer B, Hartmann C, Herold-Mende C, Reifenberger G, von Deimling A, Boutros M. The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis. Embo Molecular Medicine. 4: 38-51. PMID 22147553 DOI: 10.1002/emmm.201100186  0.68
2012 Adeberg S, Hartmann C, Welzel T, Rieken S, Habermehl D, von Deimling A, Debus J, Combs SE. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 83: 859-64. PMID 22137023 DOI: 10.1016/j.ijrobp.2011.08.010  0.68
2012 Capper D, Simon M, Langhans CD, Okun JG, Tonn JC, Weller M, von Deimling A, Hartmann C. 2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size. International Journal of Cancer. Journal International Du Cancer. 131: 766-8. PMID 21913188 DOI: 10.1002/ijc.26425  0.68
2011 Preusser M, Capper D, Hartmann C. IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee. Clinical Neuropathology. 30: 217-30. PMID 21955925 DOI: 10.5414/NP300422  0.68
2011 Combs SE, Rieken S, Wick W, Abdollahi A, von Deimling A, Debus J, Hartmann C. Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back? Radiation Oncology (London, England). 6: 115. PMID 21910919 DOI: 10.1186/1748-717X-6-115  0.68
2011 Jung CS, Unterberg AW, Hartmann C. Diagnostic markers for glioblastoma. Histology and Histopathology. 26: 1327-41. PMID 21870336  0.68
2011 Sahm F, Capper D, Meyer J, Hartmann C, Herpel E, Andrulis M, Mechtersheimer G, Petersen I, Paulus W, von Deimling A. Immunohistochemical analysis of 1844 human epithelial and haematopoietic tumours and sarcomas for IDH1R132H mutation. Histopathology. 58: 1167-72. PMID 21707716 DOI: 10.1111/j.1365-2559.2011.03823.x  0.68
2011 Nagel AM, Bock M, Hartmann C, Gerigk L, Neumann JO, Weber MA, Bendszus M, Radbruch A, Wick W, Schlemmer HP, Semmler W, Biller A. The potential of relaxation-weighted sodium magnetic resonance imaging as demonstrated on brain tumors. Investigative Radiology. 46: 539-47. PMID 21577129 DOI: 10.1097/RLI.0b013e31821ae918  0.68
2011 Elsir T, Qu M, Berntsson SG, Orrego A, Olofsson T, Lindström MS, Nistér M, von Deimling A, Hartmann C, Ribom D, Smits A. PROX1 is a predictor of survival for gliomas WHO grade II. British Journal of Cancer. 104: 1747-54. PMID 21559010 DOI: 10.1038/bjc.2011.162  0.68
2011 Hartmann C, Hentschel B, Tatagiba M, Schramm J, Schnell O, Seidel C, Stein R, Reifenberger G, Pietsch T, von Deimling A, Loeffler M, Weller M. Molecular markers in low-grade gliomas: predictive or prognostic? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4588-99. PMID 21558404 DOI: 10.1158/1078-0432.CCR-10-3194  0.68
2011 Gronych J, Korshunov A, Bageritz J, Milde T, Jugold M, Hambardzumyan D, Remke M, Hartmann C, Witt H, Jones DT, Witt O, Heiland S, Bendszus M, Holland EC, Pfister S, et al. An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice. The Journal of Clinical Investigation. 121: 1344-8. PMID 21403401 DOI: 10.1172/JCI44656  0.68
2011 Grauer O, Pascher C, Hartmann C, Zeman F, Weller M, Proescholdt M, Brawanski A, Pietsch T, Wick W, Bogdahn U, Hau P. Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). Journal of Neuro-Oncology. 104: 801-9. PMID 21373969 DOI: 10.1007/s11060-011-0548-y  0.68
2011 Barbus S, Tews B, Karra D, Hahn M, Radlwimmer B, Delhomme N, Hartmann C, Felsberg J, Krex D, Schackert G, Martinez R, Reifenberger G, Lichter P. Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors. Journal of the National Cancer Institute. 103: 598-606. PMID 21346226 DOI: 10.1093/jnci/djr036  0.68
2011 Woehrer A, Sander P, Haberler C, Kern S, Maier H, Preusser M, Hartmann C, Kros JM, Hainfellner JA. FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS). Clinical Neuropathology. 30: 47-55. PMID 21329613 DOI: 10.5414/NPP30047  0.68
2011 Prada J, Schruender S, Ngo-Tu T, Baatz H, Hartmann C, Pleyer U. Expression of tumor necrosis factor-α and interleukin-6 in corneal cells after excimer laser ablation in Wistar rats. Eye (London, England). 25: 534-6. PMID 21293497 DOI: 10.1038/eye.2011.6  0.68
2011 Kunz M, Thon N, Eigenbrod S, Hartmann C, Egensperger R, Herms J, Geisler J, la Fougere C, Lutz J, Linn J, Kreth S, von Deimling A, Tonn JC, Kretzschmar HA, Pöpperl G, et al. Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro-Oncology. 13: 307-16. PMID 21292686 DOI: 10.1093/neuonc/noq196  0.68
2011 Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathologica. 121: 397-405. PMID 21274720 DOI: 10.1007/s00401-011-0802-6  0.68
2011 Bertelmann E, Hartmann C, Minko N. [Intraorbital cavernous hemangiomas: symptoms, diagnostics and surgical approaches]. Klinische MonatsbläTter FüR Augenheilkunde. 228: 49-53. PMID 21249613 DOI: 10.1055/s-0029-1245961  0.68
2011 von Deimling A, Korshunov A, Hartmann C. The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations. Brain Pathology (Zurich, Switzerland). 21: 74-87. PMID 21129061 DOI: 10.1111/j.1750-3639.2010.00454.x  0.68
2011 Capper D, Reuss D, Schittenhelm J, Hartmann C, Bremer J, Sahm F, Harter PN, Jeibmann A, von Deimling A. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathologica. 121: 241-52. PMID 21069360 DOI: 10.1007/s00401-010-0770-2  0.68
2011 Combs SE, Schulz-Ertner D, Debus J, von Deimling A, Hartmann C. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. International Journal of Radiation Oncology, Biology, Physics. 81: 1415-21. PMID 20932661 DOI: 10.1016/j.ijrobp.2010.07.039  0.68
2011 Pusch S, Sahm F, Meyer J, Mittelbronn M, Hartmann C, von Deimling A. Glioma IDH1 mutation patterns off the beaten track. Neuropathology and Applied Neurobiology. 37: 428-30. PMID 20874727 DOI: 10.1111/j.1365-2990.2010.01127.x  0.68
2011 Brehmer S, Pusch S, Schmieder K, von Deimling A, Hartmann C. Mutational analysis of D2HGDH and L2HGDH in brain tumours without IDH1 or IDH2 mutations. Neuropathology and Applied Neurobiology. 37: 330-2. PMID 20727073 DOI: 10.1111/j.1365-2990.2010.01114.x  0.68
2011 Toedt G, Barbus S, Wolter M, Felsberg J, Tews B, Blond F, Sabel MC, Hofmann S, Becker N, Hartmann C, Ohgaki H, von Deimling A, Wiestler OD, Hahn M, Lichter P, et al. Molecular signatures classify astrocytic gliomas by IDH1 mutation status. International Journal of Cancer. Journal International Du Cancer. 128: 1095-103. PMID 20473936 DOI: 10.1002/ijc.25448  0.68
2010 Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathologica. 120: 707-18. PMID 21088844 DOI: 10.1007/s00401-010-0781-z  0.68
2010 Capper D, Sahm F, Hartmann C, Meyermann R, von Deimling A, Schittenhelm J. Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. The American Journal of Surgical Pathology. 34: 1199-204. PMID 20661018 DOI: 10.1097/PAS.0b013e3181e7740d  0.68
2010 Andrulis M, Capper D, Meyer J, Penzel R, Hartmann C, Zentgraf H, von Deimling A. IDH1 R132H mutation is a rare event in myeloproliferative neoplasms as determined by a mutation specific antibody. Haematologica. 95: 1797-8. PMID 20534697 DOI: 10.3324/haematol.2010.024430  0.68
2010 Seiz M, Tuettenberg J, Meyer J, Essig M, Schmieder K, Mawrin C, von Deimling A, Hartmann C. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes. Acta Neuropathologica. 120: 261-7. PMID 20514489 DOI: 10.1007/s00401-010-0701-2  0.68
2010 Andrulis M, Capper D, Luft T, Hartmann C, Zentgraf H, von Deimling A. Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing. Leukemia Research. 34: 1091-3. PMID 20227112 DOI: 10.1016/j.leukres.2010.02.014  0.68
2010 Combs SE, Hartmann C, Nikoghosyan A, Jäkel O, Karger CP, Haberer T, von Deimling A, Münter MW, Huber PE, Debus J, Schulz-Ertner D. Carbon ion radiation therapy for high-risk meningiomas. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 95: 54-9. PMID 20189258 DOI: 10.1016/j.radonc.2009.12.029  0.68
2010 Capper D, Weissert S, Balss J, Habel A, Meyer J, Jäger D, Ackermann U, Tessmer C, Korshunov A, Zentgraf H, Hartmann C, von Deimling A. Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathology (Zurich, Switzerland). 20: 245-54. PMID 19903171 DOI: 10.1111/j.1750-3639.2009.00352.x  0.68
2010 Weiler M, Hartmann C, Wiewrodt D, Herrlinger U, Gorlia T, Bähr O, Meyermann R, Bamberg M, Tatagiba M, von Deimling A, Weller M, Wick W. Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide. International Journal of Radiation Oncology, Biology, Physics. 77: 670-6. PMID 19836157 DOI: 10.1016/j.ijrobp.2009.05.031  0.68
2010 Meyer J, Pusch S, Balss J, Capper D, Mueller W, Christians A, Hartmann C, von Deimling A. PCR- and restriction endonuclease-based detection of IDH1 mutations. Brain Pathology (Zurich, Switzerland). 20: 298-300. PMID 19744125 DOI: 10.1111/j.1750-3639.2009.00327.x  0.68
2009 Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5874-80. PMID 19901110 DOI: 10.1200/JCO.2009.23.6497  0.68
2009 Ernst A, Hofmann S, Ahmadi R, Becker N, Korshunov A, Engel F, Hartmann C, Felsberg J, Sabel M, Peterziel H, Durchdewald M, Hess J, Barbus S, Campos B, Starzinski-Powitz A, et al. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6541-50. PMID 19861460 DOI: 10.1158/1078-0432.CCR-09-0695  0.68
2009 Pfister S, Hartmann C, Korshunov A. Histology and molecular pathology of pediatric brain tumors. Journal of Child Neurology. 24: 1375-86. PMID 19841426 DOI: 10.1177/0883073809339213  0.68
2009 Weller M, Felsberg J, Hartmann C, Berger H, Steinbach JP, Schramm J, Westphal M, Schackert G, Simon M, Tonn JC, Heese O, Krex D, Nikkhah G, Pietsch T, Wiestler O, et al. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5743-50. PMID 19805672 DOI: 10.1200/JCO.2009.23.0805  0.68
2009 Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A. Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathologica. 118: 599-601. PMID 19798509 DOI: 10.1007/s00401-009-0595-z  0.68
2009 Ahmadi R, Rezvan A, Dictus C, Christine D, Hartmann C, Christian H, Zürn O, Olga Z, Edler L, Lutz E, Hartmann M, Marius H, Combs S, Stephanie C, Herold-Mende C, et al. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochirurgica. 151: 1359-65. PMID 19575144 DOI: 10.1007/s00701-009-0435-x  0.68
2009 Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathologica. 118: 469-74. PMID 19554337 DOI: 10.1007/s00401-009-0561-9  0.68
2009 Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H, Pfister S, von Deimling A, Hartmann C. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathologica. 118: 401-5. PMID 19543740 DOI: 10.1007/s00401-009-0550-z  0.68
2009 Rieber J, Remke M, Hartmann C, Korshunov A, Burkhardt B, Sturm D, Mechtersheimer G, Wittmann A, Greil J, Blattmann C, Witt O, Behnisch W, Halatsch ME, Orakcioglu B, von Deimling A, et al. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome. Genes, Chromosomes & Cancer. 48: 558-68. PMID 19378321 DOI: 10.1002/gcc.20665  0.68
2009 Hartmann C, von Deimling A. Molecular pathology of oligodendroglial tumors. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 171: 25-49. PMID 19322536 DOI: 10.1007/978-3-540-31206-2_2  0.68
2009 Nord H, Hartmann C, Andersson R, Menzel U, Pfeifer S, Piotrowski A, Bogdan A, Kloc W, Sandgren J, Olofsson T, Hesselager G, Blomquist E, Komorowski J, von Deimling A, Bruder CE, et al. Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array. Neuro-Oncology. 11: 803-18. PMID 19304958 DOI: 10.1215/15228517-2009-013  0.68
2009 Capper D, Gaiser T, Hartmann C, Habel A, Mueller W, Herold-Mende C, von Deimling A, Siegelin MD. Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation. Acta Neuropathologica. 117: 445-56. PMID 19214542 DOI: 10.1007/s00401-009-0494-3  0.68
2009 Ahmadi R, Dictus C, Hartmann C, Zürn O, Edler L, Hartmann M, Combs S, Herold-Mende C, Wirtz CR, Unterberg A. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients (Acta Neurochir (DOI: 10.1007/s00701-009- 0435-x)) Acta Neurochirurgica. 151: 1367. DOI: 10.1007/s00701-009-0473-4  0.68
2008 Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathologica. 116: 597-602. PMID 18985363 DOI: 10.1007/s00401-008-0455-2  0.68
2007 Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6933-7. PMID 18056167 DOI: 10.1158/1078-0432.CCR-07-0573  0.68
2007 Holtkamp N, Atallah I, Okuducu AF, Mucha J, Hartmann C, Mautner VF, Friedrich RE, Mawrin C, von Deimling A. MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors. Neoplasia (New York, N.Y.). 9: 671-7. PMID 17786186 DOI: 10.1593/neo.07304  0.68
2007 Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G. Long-term survival with glioblastoma multiforme. Brain : a Journal of Neurology. 130: 2596-606. PMID 17785346 DOI: 10.1093/brain/awm204  0.68
2007 Fiss I, Danne M, Hartmann C, Brock M, Stendel R. Rapidly progressive paraplegia due to an extradural lumbar meningocele mimicking a cyst. Case report. Journal of Neurosurgery. Spine. 7: 75-9. PMID 17633492 DOI: 10.3171/SPI-07/07/075  0.68
2007 Kunitz A, Wolter M, van den Boom J, Felsberg J, Tews B, Hahn M, Benner A, Sabel M, Lichter P, Reifenberger G, von Deimling A, Hartmann C. DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas. Brain Pathology (Zurich, Switzerland). 17: 363-70. PMID 17610521 DOI: 10.1111/j.1750-3639.2007.00083.x  0.68
2007 Holtkamp N, Ziegenhagen N, Malzer E, Hartmann C, Giese A, von Deimling A. Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme. Neuro-Oncology. 9: 291-7. PMID 17504929 DOI: 10.1215/15228517-2007-009  0.68
2007 Simon M, Boström JP, Hartmann C. Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery. 60: 787-98; discussion 7. PMID 17460514 DOI: 10.1227/01.NEU.0000255421.78431.AE  0.68
2007 Stockhammer F, Thomale UW, Plotkin M, Hartmann C, Von Deimling A. Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas. Journal of Neurosurgery. 106: 633-7. PMID 17432715 DOI: 10.3171/jns.2007.106.4.633  0.68
2007 Tews B, Roerig P, Hartmann C, Hahn M, Felsberg J, Blaschke B, Sabel M, Kunitz A, Toedt G, Neben K, Benner A, von Deimling A, Reifenberger G, Lichter P. Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene. 26: 5010-6. PMID 17311001 DOI: 10.1038/sj.onc.1210297  0.68
2007 Rickert CH, Schwering EM, Siebers J, Hartmann C, von Deimling A, Paulus W. Chromosomal imbalances and NF2 mutational analysis in a series of 10 spinal nerve sheath myxomas. Histopathology. 50: 252-7. PMID 17222254 DOI: 10.1111/j.1365-2559.2007.02579.x  0.68
2006 Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A. NF2 mutations in secretory and other rare variants of meningiomas. Brain Pathology (Zurich, Switzerland). 16: 15-9. PMID 16612978  0.68
2006 Hartmann C, Devermann L, Gehlhaar C, Holtkamp N, von Deimling A. PIK3CA mutations in oligodendroglial tumours. Neuropathology and Applied Neurobiology. 32: 209-12. PMID 16599949 DOI: 10.1111/j.1365-2990.2006.00700.x  0.68
2006 Tews B, Felsberg J, Hartmann C, Kunitz A, Hahn M, Toedt G, Neben K, Hummerich L, von Deimling A, Reifenberger G, Lichter P. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. International Journal of Cancer. Journal International Du Cancer. 119: 792-800. PMID 16550607 DOI: 10.1002/ijc.21901  0.68
2006 Kohnen T, Allen D, Boureau C, Dublineau P, Hartmann C, Mehdorn E, Rozot P, Tassinari G. European multicenter study of the AcrySof ReSTOR apodized diffractive intraocular lens. Ophthalmology. 113: 584.e1. PMID 16483658 DOI: 10.1016/j.ophtha.2005.11.020  0.68
2006 Holtkamp N, Okuducu AF, Mucha J, Afanasieva A, Hartmann C, Atallah I, Estevez-Schwarz L, Mawrin C, Friedrich RE, Mautner VF, von Deimling A. Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity. Carcinogenesis. 27: 664-71. PMID 16357008 DOI: 10.1093/carcin/bgi273  0.68
2005 Wemmert S, Ketter R, Rahnenführer J, Beerenwinkel N, Strowitzki M, Feiden W, Hartmann C, Lengauer T, Stockhammer F, Zang KD, Meese E, Steudel WI, von Deimling A, Urbschat S. Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment. Neoplasia (New York, N.Y.). 7: 883-93. PMID 16242071 DOI: 10.1593/neo.05307  0.68
2005 Hartmann C, von Deimling A. Oligodendrogliomas: impact of molecular genetics on treatment. Neurology India. 53: 140-8. PMID 16010049  0.68
2005 Díaz de StÃ¥hl T, Hartmann C, de Bustos C, Piotrowski A, Benetkiewicz M, Mantripragada KK, Tykwinski T, von Deimling A, Dumanski JP. Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme. Genes, Chromosomes & Cancer. 44: 161-9. PMID 15945096 DOI: 10.1002/gcc.20226  0.68
2005 Hartmann C, Bartels G, Gehlhaar C, Holtkamp N, von Deimling A. PIK3CA mutations in glioblastoma multiforme. Acta Neuropathologica. 109: 639-42. PMID 15924253 DOI: 10.1007/s00401-005-1000-1  0.68
2003 Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Research. 63: 1602-7. PMID 12670911  0.68
2003 Heinrich B, Hartmann C, Stemmer-Rachamimov AO, Louis DN, MacCollin M. Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms. International Journal of Cancer. Journal International Du Cancer. 103: 483-8. PMID 12478663 DOI: 10.1002/ijc.10840  0.68
2002 Hartmann C, Johnk L, Kitange G, Wu Y, Ashworth LK, Jenkins RB, Louis DN. Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19. Cancer Research. 62: 4100-8. PMID 12124348  0.68
2002 Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von Deimling A. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. The American Journal of Pathology. 161: 313-9. PMID 12107116 DOI: 10.1016/S0002-9440(10)64183-1  0.68
2002 Hartmann C, Johnk L, Sasaki H, Jenkins RB, Louis DN. Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas. Brain Pathology (Zurich, Switzerland). 12: 178-82. PMID 11958371  0.68
2000 Park CC, Hartmann C, Folkerth R, Loeffler JS, Wen PY, Fine HA, Black PM, Shafman T, Louis DN. Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones. Journal of Neuropathology and Experimental Neurology. 59: 1044-50. PMID 11138924  0.68
Show low-probability matches.